Researchers found that individuals have distinct baseline levels of brain-derived proteins in cerebrospinal fluid, masking ...
In this Innovation Spotlight, Dan Levangie, president and chief executive officer of CereVasc, discusses a new treatment strategy for NPH using an endovascularly implantable CSF shunt that minimizes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results